Your browser is no longer supported. Please, upgrade your browser.
NRx Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-7.60 Insider Own1.30% Shs Outstand41.73M Perf Week47.63%
Market Cap618.37M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float18.83M Perf Month-2.29%
Income-298.50M PEG- EPS next Q- Inst Own4.00% Short Float9.03% Perf Quarter-17.12%
Sales- P/S- EPS this Y-596.10% Inst Trans-0.04% Short Ratio0.27 Perf Half Y-66.71%
Book/sh-0.42 P/B- EPS next Y- ROA- Target Price- Perf Year-4.20%
Cash/sh0.22 P/C46.15 EPS next 5Y- ROE- 52W Range6.43 - 76.99 Perf YTD-57.95%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-86.67% Beta0.25
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin- 52W Low59.68% ATR1.43
Employees2 Current Ratio0.50 Sales Q/Q- Oper. Margin- RSI (14)50.11 Volatility25.41% 12.38%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.73 Prev Close11.91
ShortableYes LT Debt/Eq- EarningsAug 16 AMC Payout- Avg Volume6.32M Price10.26
Recom- SMA209.20% SMA50-14.83% SMA200-57.63% Volume4,615,992 Change-13.85%
Oct-14-21 06:48AM  
Oct-12-21 06:48AM  
Sep-29-21 06:48AM  
Sep-27-21 07:04AM  
Sep-08-21 07:48AM  
Aug-30-21 08:06AM  
Aug-26-21 06:48AM  
Aug-25-21 09:43AM  
Aug-24-21 06:48AM  
Aug-23-21 09:33AM  
Aug-19-21 09:17AM  
Aug-18-21 11:53AM  
Aug-16-21 09:32PM  
Aug-11-21 04:20PM  
Aug-10-21 06:48AM  
Aug-09-21 01:13PM  
Aug-04-21 06:48AM  
Jul-27-21 11:34AM  
Jul-22-21 06:48AM  
Jul-19-21 06:48AM  
Jul-12-21 11:18AM  
Jul-06-21 09:20AM  
Jun-15-21 07:33AM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
Jun-07-21 01:45PM  
Jun-01-21 06:28AM  
May-27-21 06:48AM  
May-26-21 09:29AM  
NRx Pharmaceuticals, Inc. a clinical-stage, small molecule pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was incorporated in 2015 and is headquartered in Wilmington, Delaware.